1. NCCU Academic Hub
  2. Publications
  3. College of Commerce
  4. Theses
  5. Item

Publications-Theses

Article View/Open

Publication Export

Google ScholarTM

NCCU Library

Citation Infomation

Related Publications in TAIR

題名 在美國和台灣的健保制度下，製藥業是如何適應新的數位化的改變
How the Pharmaceutical Industry Adapts to the newly Digital regime? The Comparison Study between Taiwan and the U.S. Healthcare System
作者 楊筑鈞
Yang, Ju-Jiun
貢獻者 彭朱如<br>黃國峯
Peng, Tzu-Ju<br>Huang, Kuo-Feng
楊筑鈞
Yang, Ju-Jiun
關鍵詞 美國
台灣
健保制度
製藥業
數位化
改變
Pharmaceutical
Adapts
Digital
Comparison
Taiwan
U.S.
日期 2019
上傳時間 5-Sep-2019 17:33:29 (UTC+8)
摘要 Abstract
The healthcare system of the United States can be seen as a complete opposite spectrum compared to the Taiwan healthcare system. Taiwan’s healthcare system focuses on providing medical help at lower costs for the current population at a high-speed rate. Whereas the United
States is looking at providing medical assist at higher costs with the most current and higher cost medical technology. In this context, what can we define as the biggest difference between the two systems? At the same time, what are the pros and cons of each system?
In addition, we are also going to look at how new digital innovations has taken each healthcare
system so far in the current society. What kind of digital innovation techniques has the Taiwan medical system been implementing compared to the United States? Based on a specific case regarding an international pharmaceutical company, we can take a closer look at how exactly new
digital techniques has taken revolution from the past until now.
參考文獻 Reference

Abutaleb, Yasmeen.(2018), “U.S. healthcare spending to climb 5.3 percent in 2018:
agency,” Health News, https://www.reuters.com/article/us-usa-healthcare-spending/ushealthcare-
spending-to-climb-53-percent-in-2018-agency-idUSKCN1FY2ZD

Ajit, Kumar. Sanjeev, Maskara.(2015), “U.S. versus Taiwan Healthcare System Reforms:
What Can India Learn from them,” American Journal of Industrial and Business Management,
Vol.5, 119-144.

Amadeo, Kimberly.(2019), “The Rising Cost of health Care by Year and Its Causes,” The
Balance, https://www.thebalance.com/causes-of-rising-healthcare-costs-4064878

Camillo, Cheryl.(2016), “The U.S. Healthcare System: Complex and Unequal,” Global
Social Welfare, Vol.3, No.2

Chakravarty, Sudeep.(2019), “World’s Top 10 Pharmaceutical Companies by Revenue,”
Market Research Reports,
https://www.marketresearchreports.com/blog/2019/01/30/world%E2%80%99s-top-10-
pharmaceutical-companies-revenue

Cheng, Tsung-Mei.(2019), “Health Care Spending In the US and Taiwan: A Response To
It’s Still the Prices, Stupid, And A Tribute To Uwe Reinhardt,” Health Affairs Blog,
https://www.healthaffairs.org/do/10.1377/hblog20190206.305164/full/

Cohen, Jessica.(2018), “Amazon, Merck, Accenture to launch data-driven drug
development platform,” Becker’s Hospital Review,
https://www.beckershospitalreview.com/supply-chain/amazon-merck-accenture-to-launch-datadriven-
drug-development-platform.html

Devine, T.(2017), “Merck & Co. is working with Amazon Web Services (AWS) to
explore the creation and delivery of digital initiatives for people living with chronic disease by using Amazon Lex, the deep learning technologies that power Amazon Alexa. (TECH Talk),” Chain Drug Review, Vol.39, No.9, 53.

Dirngal, Andreas. Cocoli, Myrvet.(2016), “Global Generic Pharmaceutical Industry
Review,” CRD-Healthcare, https://www.krungsri.com/bank/getmedia/a5599675-701b-49d8-
a857-33d247c773a0/BTMU-Research-201602-29.aspx

Ellis, Monique.(2019), “Top 10 pharmaceutical companies in 2019,” Proclinical,
https://www.proclinical.com/blogs/2019-3/the-top-10-pharmaceutical-companies-in-the-world-2019

Frakt, Austin. Carroll, Aaron.(2013), “The Quality Imperative A Commentary on theU.S. Healthcare System,” American Journal of Preventive Medicine, Vol.44, No.1S1, S22-S26.

Ho, Cai-Wei.(2018), “A Study on the Operation Strategies of Prescription Generic Firms-
A case study of S Company,”
http://ntcuir.ntcu.edu.tw/bitstream/987654321/13414/2/NEM105108.pdf

Kamangar, F. Millsop, JW. Tsai, D.(2015), “What can U.S. dermatology learn from
health care systems abroad? An observation of Taiwan’s system of clinical efficiency as a
possible model for increased patient access to care and affordability,” Dermatol Online J,
Vol.21, No.5

Kaiser, Henry.(2018), “Key Facts about the Uninsured Population,” KFF,
https://www.kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population/

Kasi, Adam.(2017), “Porter Five Forces Analysis of US Pharmaceutical Industry,”
Industries, https://www.porteranalysis.com/porter-five-forces-analysis-of-us-pharmaceuticalindustry/

Leonard, Kwok-han.(2013), “Drug makers are the midst of a digital revolution:
pharmaceutical firms are sharpening their focus on multichannel marketing and analytics,” CRM
Magazine, Vol.17, No.7, 22.

Madisha, Lusi.(2018), “Difference between Qualitative Analysis and Quantitative
Anaylsis,” Difference Between.net, http://www.differencebetween.net/science/differencebetween-
qualitative-analysis-and-quantitative-analysis/

Manz, Christopher. Ross, Joseph. Grande, David.(2014), “Marketing to Physicians in a
Digital World,” The New England Journal of Medicine, Vol.371, 1857-1859.

Membrillo, Alex.(2019), “Healthcare Digital Marketing Trends to Expect in 2019,” Cardinal, https://www.cardinaldigitalmarketing.com/blog/healthcare-digital-marketing-trendsinnovations-
seo-ppc-2019/

Merck.(2018), “Redefining Health Care with Digital Innovation,”
https://www.merck.com/about/featured-stories/austin.html

Nathan, Jay. Venkatatraman, Ray.(1999), “Management of quality, capacity, and
productivity at Merck.” Hospital Materiel Management Quarterly, Vol.20, No.3, 64.

Porter, Michael.(1979), “How Competitive Forces Shape Strategy,” Harvard Business Review, Vol.57, 137-145

Puhl, N. Woulfe, J. “Healthcare Sector Report.AMP,”
http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=13208

Rau, Hsiao-Hsien. Hsu, Chien-Yeh.(2010), “Developing electronic health records in Taiwan,” IT professional, Vol.12, 17-25

Sands, Rory.(2013), “Porters 5 Forces-Pharmaceutical Industry,”
https://prezi.com/h5l8wrg2f6rr/porters-5-forces-pharmaceutical-industry/

Sharma, Ankit.(2018), “Role of Digital Marketing in Healthcare Industry,” AeroLeads,
https://aeroleads.com/blog/role-digital-marketing-health-care-industry/

Wang, Guang-Xu.(2012), “A network approach for researching political feasibility of
healthcare reform: The case of universal healthcare system in Taiwan,” Social Science &
Medicine, Vol.75, 2337-2344.

Whiteside, Eric.(2016), “The Industry Handbook: Pharma Industry,” Investopedia,
https://www.investopedia.com/articles/markets/051316/industry-handbook-pharma-industry.asp
描述 碩士
國立政治大學
企業管理研究所(MBA學位學程)
105363126
資料來源 http://thesis.lib.nccu.edu.tw/record/#G0105363126
資料類型 thesis
dc.contributor.advisor 彭朱如<br>黃國峯zh_TW
dc.contributor.advisor Peng, Tzu-Ju<br>Huang, Kuo-Fengen_US
dc.contributor.author (Authors) 楊筑鈞zh_TW
dc.contributor.author (Authors) Yang, Ju-Jiunen_US
dc.creator (作者) 楊筑鈞zh_TW
dc.creator (作者) Yang, Ju-Jiunen_US
dc.date (日期) 2019en_US
dc.date.accessioned 5-Sep-2019 17:33:29 (UTC+8)-
dc.date.available 5-Sep-2019 17:33:29 (UTC+8)-
dc.date.issued (上傳時間) 5-Sep-2019 17:33:29 (UTC+8)-
dc.identifier (Other Identifiers) G0105363126en_US
dc.identifier.uri (URI) http://nccur.lib.nccu.edu.tw/handle/140.119/125939-
dc.description (描述) 碩士zh_TW
dc.description (描述) 國立政治大學zh_TW
dc.description (描述) 企業管理研究所(MBA學位學程)zh_TW
dc.description (描述) 105363126zh_TW
dc.description.abstract (摘要) Abstract
The healthcare system of the United States can be seen as a complete opposite spectrum compared to the Taiwan healthcare system. Taiwan’s healthcare system focuses on providing medical help at lower costs for the current population at a high-speed rate. Whereas the United
States is looking at providing medical assist at higher costs with the most current and higher cost medical technology. In this context, what can we define as the biggest difference between the two systems? At the same time, what are the pros and cons of each system?
In addition, we are also going to look at how new digital innovations has taken each healthcare
system so far in the current society. What kind of digital innovation techniques has the Taiwan medical system been implementing compared to the United States? Based on a specific case regarding an international pharmaceutical company, we can take a closer look at how exactly new
digital techniques has taken revolution from the past until now.		en_US
dc.description.tableofcontents Contents Page

Abstract 4
1. Introduction 4
1.1 Research Background and Motivations 5
1.2 Research Questions and Objective 5
2. Literature Review 7
2.1 Taiwan Healthcare vs U.S. Healthcare 7
2.2 The Industry Analysis-Five Force Analysis 8
2.3 Digital Innovations 9
3. The U.S. and Taiwan’s Healthcare System 11
3.1. Healthcare System Introduction 11
3.1.1 The U.S. Healthcare System 11
Possible Sources of health insurance 13
Low-Income Persons’ Access to Health Insurance Coverage and Care 14
The Affordable Care Act (ACA) 15
3.1.2. Taiwan’s Healthcare System 16
Taiwan Electronic Medical Record Template (TMT) 18
3.1.3. The Comparison of the US and Taiwan’s Healthcare System 20
3.2 Five Force Analysis 21
3.2.1. The US Pharmaceutical Industry Analysis 21
3.2.2. The Taiwan Pharmaceutical Industry Analysis 24
3.2.3. Comparison of the US and Taiwan Pharmaceutical Industry Analysis 26
4. Digital Innovations 28
4.1. U.S. Health Digital Innovations Techniques 28
4.2 Taiwan Health Digital Innovation Techniques 29
4.3. The Comparison of the US and Taiwan’s Digital Innovation Techniques 32
5. Case Study and Discussion 34
Reference 41


Table of Contents

Figure - 1 (Porter 1979) 9
Table - 1 U.S vs Taiwan. Healthcare System Comparison Chart 21
Table - 2 Generic vs Brand-name Drugs (Dirnagl, Cocoli 2016) 25
Table - 3 Comparison of Taiwan vs U.S. (Porter’s Five Force) 27
Table - 4 Digital Innovation Success rate in Taiwan vs U.S. 33		zh_TW
dc.format.extent 1931617 bytes-
dc.format.mimetype application/pdf-
dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0105363126en_US
dc.subject (關鍵詞) 美國zh_TW
dc.subject (關鍵詞) 台灣zh_TW
dc.subject (關鍵詞) 健保制度zh_TW
dc.subject (關鍵詞) 製藥業zh_TW
dc.subject (關鍵詞) 數位化zh_TW
dc.subject (關鍵詞) 改變zh_TW
dc.subject (關鍵詞) Pharmaceuticalen_US
dc.subject (關鍵詞) Adaptsen_US
dc.subject (關鍵詞) Digitalen_US
dc.subject (關鍵詞) Comparisonen_US
dc.subject (關鍵詞) Taiwanen_US
dc.subject (關鍵詞) U.S.en_US
dc.title (題名) 在美國和台灣的健保制度下，製藥業是如何適應新的數位化的改變zh_TW
dc.title (題名) How the Pharmaceutical Industry Adapts to the newly Digital regime? The Comparison Study between Taiwan and the U.S. Healthcare Systemen_US
dc.type (資料類型) thesisen_US
dc.relation.reference (參考文獻) Reference

Abutaleb, Yasmeen.(2018), “U.S. healthcare spending to climb 5.3 percent in 2018:
agency,” Health News, https://www.reuters.com/article/us-usa-healthcare-spending/ushealthcare-
spending-to-climb-53-percent-in-2018-agency-idUSKCN1FY2ZD

Ajit, Kumar. Sanjeev, Maskara.(2015), “U.S. versus Taiwan Healthcare System Reforms:
What Can India Learn from them,” American Journal of Industrial and Business Management,
Vol.5, 119-144.

Amadeo, Kimberly.(2019), “The Rising Cost of health Care by Year and Its Causes,” The
Balance, https://www.thebalance.com/causes-of-rising-healthcare-costs-4064878

Camillo, Cheryl.(2016), “The U.S. Healthcare System: Complex and Unequal,” Global
Social Welfare, Vol.3, No.2

Chakravarty, Sudeep.(2019), “World’s Top 10 Pharmaceutical Companies by Revenue,”
Market Research Reports,
https://www.marketresearchreports.com/blog/2019/01/30/world%E2%80%99s-top-10-
pharmaceutical-companies-revenue

Cheng, Tsung-Mei.(2019), “Health Care Spending In the US and Taiwan: A Response To
It’s Still the Prices, Stupid, And A Tribute To Uwe Reinhardt,” Health Affairs Blog,
https://www.healthaffairs.org/do/10.1377/hblog20190206.305164/full/

Cohen, Jessica.(2018), “Amazon, Merck, Accenture to launch data-driven drug
development platform,” Becker’s Hospital Review,
https://www.beckershospitalreview.com/supply-chain/amazon-merck-accenture-to-launch-datadriven-
drug-development-platform.html

Devine, T.(2017), “Merck & Co. is working with Amazon Web Services (AWS) to
explore the creation and delivery of digital initiatives for people living with chronic disease by using Amazon Lex, the deep learning technologies that power Amazon Alexa. (TECH Talk),” Chain Drug Review, Vol.39, No.9, 53.

Dirngal, Andreas. Cocoli, Myrvet.(2016), “Global Generic Pharmaceutical Industry
Review,” CRD-Healthcare, https://www.krungsri.com/bank/getmedia/a5599675-701b-49d8-
a857-33d247c773a0/BTMU-Research-201602-29.aspx

Ellis, Monique.(2019), “Top 10 pharmaceutical companies in 2019,” Proclinical,
https://www.proclinical.com/blogs/2019-3/the-top-10-pharmaceutical-companies-in-the-world-2019

Frakt, Austin. Carroll, Aaron.(2013), “The Quality Imperative A Commentary on theU.S. Healthcare System,” American Journal of Preventive Medicine, Vol.44, No.1S1, S22-S26.

Ho, Cai-Wei.(2018), “A Study on the Operation Strategies of Prescription Generic Firms-
A case study of S Company,”
http://ntcuir.ntcu.edu.tw/bitstream/987654321/13414/2/NEM105108.pdf

Kamangar, F. Millsop, JW. Tsai, D.(2015), “What can U.S. dermatology learn from
health care systems abroad? An observation of Taiwan’s system of clinical efficiency as a
possible model for increased patient access to care and affordability,” Dermatol Online J,
Vol.21, No.5

Kaiser, Henry.(2018), “Key Facts about the Uninsured Population,” KFF,
https://www.kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population/

Kasi, Adam.(2017), “Porter Five Forces Analysis of US Pharmaceutical Industry,”
Industries, https://www.porteranalysis.com/porter-five-forces-analysis-of-us-pharmaceuticalindustry/

Leonard, Kwok-han.(2013), “Drug makers are the midst of a digital revolution:
pharmaceutical firms are sharpening their focus on multichannel marketing and analytics,” CRM
Magazine, Vol.17, No.7, 22.

Madisha, Lusi.(2018), “Difference between Qualitative Analysis and Quantitative
Anaylsis,” Difference Between.net, http://www.differencebetween.net/science/differencebetween-
qualitative-analysis-and-quantitative-analysis/

Manz, Christopher. Ross, Joseph. Grande, David.(2014), “Marketing to Physicians in a
Digital World,” The New England Journal of Medicine, Vol.371, 1857-1859.

Membrillo, Alex.(2019), “Healthcare Digital Marketing Trends to Expect in 2019,” Cardinal, https://www.cardinaldigitalmarketing.com/blog/healthcare-digital-marketing-trendsinnovations-
seo-ppc-2019/

Merck.(2018), “Redefining Health Care with Digital Innovation,”
https://www.merck.com/about/featured-stories/austin.html

Nathan, Jay. Venkatatraman, Ray.(1999), “Management of quality, capacity, and
productivity at Merck.” Hospital Materiel Management Quarterly, Vol.20, No.3, 64.

Porter, Michael.(1979), “How Competitive Forces Shape Strategy,” Harvard Business Review, Vol.57, 137-145

Puhl, N. Woulfe, J. “Healthcare Sector Report.AMP,”
http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=13208

Rau, Hsiao-Hsien. Hsu, Chien-Yeh.(2010), “Developing electronic health records in Taiwan,” IT professional, Vol.12, 17-25

Sands, Rory.(2013), “Porters 5 Forces-Pharmaceutical Industry,”
https://prezi.com/h5l8wrg2f6rr/porters-5-forces-pharmaceutical-industry/

Sharma, Ankit.(2018), “Role of Digital Marketing in Healthcare Industry,” AeroLeads,
https://aeroleads.com/blog/role-digital-marketing-health-care-industry/

Wang, Guang-Xu.(2012), “A network approach for researching political feasibility of
healthcare reform: The case of universal healthcare system in Taiwan,” Social Science &
Medicine, Vol.75, 2337-2344.

Whiteside, Eric.(2016), “The Industry Handbook: Pharma Industry,” Investopedia,
https://www.investopedia.com/articles/markets/051316/industry-handbook-pharma-industry.asp		zh_TW
dc.identifier.doi (DOI) 10.6814/NCCU201900824en_US